Cannabis
Statement on the Booker-Wyden-Schumer Cannabis Administration and Opportunity Act
The Global Alliance for Cannabis Commerce (GACC) is proud to announce its support of Senate Majority Leader Chuck Schumer (D-NY), Senator Ron Wyden (D-OR), and Senator Cory Booker’s (D-NJ) Cannabis Administration and Opportunity (CAO) Act.
The Act takes the important steps of descheduling cannabis entirely from the Controlled Substances Act, applying a federal regulatory framework for interstate and international trade, and works to make restitution for the damages of cannabis prohibition to communities harmed by prohibition.
The Global Alliance looks forward to working with the bill sponsors to move this bill forward through the legislative process.
According to GACC President Rezwan Khan, “Leader Schumer is doing exactly that: leading the way for a better path forward for the millions of Americans—from consumers, to employees, and businesses—affected by cannabis prohibition. The time for members of the House and Senate to end prohibition is this Congress.”
GACC Founding Board Member Sam Rodriguez added, “The regulatory framework is built upon strong economic principles of fairness and equity, harnessing it’s collective mission to stimulate innovation and social progress.”
“Leader Schumer inherited a status quo where small American cannabis businesses are marginalized and large foreign companies are prioritized in the areas of banking, taxation, and intellectual property rights,” said GACC Board Member Moe Asnani. “As a first-generation immigrant, I am glad to see the Senate Majority Leader take the first steps to elevate homegrown American cannabis.”
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care